The tariff classification of Doxorubicin Hydrochloride Liposomal Injection in dosage form, from India
Reasoning
The tariff classification of Doxorubicin Hydrochloride Liposomal Injection in dosage form, from India
Cite this ruling
CBP Ruling N344213 (3004200075): The tariff classification of Doxorubicin Hydrochloride Liposomal Injection in dosage form, from India
Paste this into a product's override reason when citing this ruling as justification for a classification.
Other rulings for HS6 300420
The tariff classification of Cefotaxime for Injection, Cefixime Tablets and Ceftriaxone for Injection, in dosage form, from China
The tariff classification of Cefdinir Capsules imported in dosage form, from India
The tariff classification of Buspirone Hydrochloride Tablets, Pramipexole Dihydrochloride Extended Release Tablets, Minocycline Hydrochloride Extended Release Tablets, imported in dosage form, from India
The tariff classification of Cefpodoxime Proxetil (CAS-87239-81-4), imported in dosage form, from India
The tariff classification of MONUROL® imported in dosage form, from Switzerland